Dr. Pierre Kory interviewed by Dr. Sam Dubé

Pierre Kory, M.D., M.P.A., President of the non-profit Front Line COVID-19 Critical Care Alliance, is interviewed by Sam Dubé, M.D., Ph.D., representing The Toronto Business Journal, on December 16th, 2020. The interview was conducted a week after Dr. Kory's impassioned testimony before the Senate Homeland Security and Governmental Affairs Committee hearing where he implored the U.S. government and its affiliated agencies, such as the FDA, NIH, and CDC, to urgently consider the compelling evidence in support of repurposing the WHO Essential Medicine ivermectin as a highly effective therapy in the prevention and treatment of COVID-19.
In this candid and informative interview, Dr. Kory elaborates significantly on the points he made during his December 8th, 2020 address to the U.S. Senate, and much more.

LINKS:

Learn more about the Front Line COVID-19 Critical Care (FLCCC) Alliance, and their mandate to research and develop prevention and treatment protocols for COVID-19, here: http://www.flccc.net​

The most recent version of the ivermectin review of evidence manuscript is available on the Open Science Framework preprint server, here: https://osf.io/wx3zn​

The FLCCC MATH+ Hospital Treatment Protocol for COVID-19 paper (which shows a 6.1% mortality rate when the Protocol is used, far lower than the worldwide average of 23%) is available here: https://covid19criticalcare.com/wp-co...​

For all respirologists and others interested, Dr. Kory's paper on SARS-CoV-2 organising pneumonia is available here: https://bmjopenrespres.bmj.com/conten...​

Technical Producers: Santhosh CHRiS
Community Producer: Ray Samuels
Website: https://www.tobj.ca​
Contact info: Peter Tremblay, Managing Editor - agorakanata@gmail.com
Premiered December 20, 2020